CPRD Clinical Practice Research Datalink

Similar documents
Experiences of using routinely collected medical data in a cardiovascular safety trial?

JH-CERSI/FDA Workshop Clinical Trials: Assessing Safety and Efficacy for a Diverse Population

POST-LAUNCH DEMANDS: Dr Thomas Lönngren ISPOR Content

European network of paediatric research (EnprEMA)

LINKING EXISTING DATABASES POISONED CHALICE OR HOLY GRAIL? Linking to THIN Data CSD MR UK ISPOR. What is THIN? What can we link? How do we do it?

How to optimise research support and funding via the UKCRN

OPERATIONAL RESEARCH. What, Why and How? Dr. Rony Zachariah MD, PhD Operational Centre Brussels MSF- Luxembourg

Preventing Heart Attacks and Strokes The Size of the Prize

MEDICINEINSIGHT: BIG DATA IN PRIMARY HEALTH CARE. Rachel Hayhurst Product Portfolio Manager, Health Informatics NPS MedicineWise

Clear and present data: how access to our medical records can help life-saving science

Example. 9 Revalidation: Planning for Rollout - Annex B. Options for roll-out. Option 1: Random approach

IIS Sponsor Reference Guide

Real World Evidence in Europe

Eligibility Criteria for NIHR Clinical Research Network Support

Registries for Evaluating Patient Outcomes:

Data for and from clinical trials

Facts and figures on the NHS at 70

Primary - Secondary Care Interface Management

Navigating the Clinical Research Landscape in the NHS. How the Clinical Research Network can help you Generate the Evidence

Newborn Screening Programmes in the United Kingdom

Physician / Investigator. Over 40% of clinical trial data are entered into health record and EDC 1

Latin America: An Evolving Regulatory Environment September 15, Mapi 2015, All Rights Reserved

1. The Department funds R&D through two main routes:

Pragmatic Trials: how early in drug development? Salford Lung Studies & IMI GetReal Project. Chris Chinn VP and Head of RWE

Medical research in the UK is a success story!

NHS CANCER SERVICES FOR CHILDREN

Improving patient safety and infection. Patient Safety Forum Dr J Coleman 1 ELECTRONIC PRESCRIBING AND CLINICAL DECISION SUPPORT (CDS)

FACULTY OF PUBLIC HEALTH DEPARTMENT OF PUBLIC HEALTH SCIENCIES

Marion Flood NHS GGC. Safe Haven

NHS Health Check Programme rapid evidence synthesis

Lorenzo for clinical outcomes transformation? Ben Bridgewater

Participant Information Sheet Adults

Effect of the British Red Cross Support at Home service on hospital utilisation

Cancer Research UK response to the Business, Innovation and Skills Committee inquiry into the Government s industrial strategy September 2016

Do quality improvements in primary care reduce secondary care costs?

NHS Research Scotland Permissions Coordinating Centre (NRS Permissions CC)

Primary medical care new workload formula for allocations to CCG areas

SPSP: Sepsis in Primary Care Collaborative. Dr Paul Davidson Associate Medical Director Primary Care NHS Highland

GP Practice Data Export and Sharing Agreement

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Access to Drugs Policy

Hong Kong Association of the Pharmaceutical Industry. Position paper on Primary Care in Hong Kong

NHS Research Scotland Permissions Coordinating Centre

The All Party Parliamentary Group on Skin Kensington Church Street, London W8 4DB

First NIHR Statistics Meeting

What data is out there? Health Statistics NSW Accessible data on the health of the NSW population

Improving the prevention, early detection and management of Acute Kidney Injury (AKI) in Wessex

Cardiovascular Health Westminster:

Statistical Analysis of the EPIRARE Survey on Registries Data Elements

Framework for Cancer CNS Development (Band 7)

SECONDARY USE OF HEALTH DATA

Data Quality in Electronic Patient Records: Why its important to assess and address. Dr Annette Gilmore PhD, MSc (Econ) BSc, RGN

Yorkshire & the Humber Acute Kidney Injury Patient Care Initiative (AKIPCI)

Background and Issues. Aim of the Workshop Analysis Of Effectiveness And Costeffectiveness. Outline. Defining a Registry

The Principal Investigator Role

Maternal and Child Health, Chronic Diseases Alaska Division of Public Health, Section of Women's, Children's, and Family Health

Imperial College Health Partners - at a glance

NIHR Funding Opportunities

Improving transparency and reproducibility of evidence from large healthcare databases with specific reporting: a workshop

Risk Management using the HITRUST De-Identification Framework

Integrating prevention into health care

LIHS Mini-masterclass: What the NIHR Research Design Service (RDS) can do to support you. Dr Maureen Twiddy and Dr Maria Bryant

Cancer Drugs Fund. Managed Access Agreement. Daratumumab monotherapy for treating relapsed and refractory multiple myeloma

Section 3: Handover record headings

Patients registered at a GP Practice

A step by step guide to using IRAS to apply to conduct research in or through the NHS/HSC.

MERMAID SERIES: SECONDARY DATA ANALYSIS: TIPS AND TRICKS

NHS Business Services Authority Burden Reduction Response

Introduction To Medpace & Clinical Research Overview

Trials in Primary Care: design, conduct and evaluation of complex interventions

St George s Healthcare NHS Trust: the next decade. Research Strategy

Clinical Research Network Kent, Surrey and Sussex. Specialty Group Clinical Lead

Routine Data Is it Good Enough for Trials. Alex Wright-Hughes Wednesday, May 23, 2012

Guidance on the prescribing of medication initiated or recommended either after a private episode of care or a referral to a tertiary NHS centre

European Reference Networks. Guidance on the recognition of Healthcare Providers and UK Oversight of Applications

Factors associated with variation in hospital use at the End of Life in England

Overview of NIHR structure, and funding streams. Prof James Mason, Co-Director, RDS NE

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Named Key Worker for Cancer Patients Policy

ICT in Northern Ireland. Dr Jimmy Courtney NIGPC

MINUTES. UK CLINICAL RESEARCH COLLABORATION (UKCRC) BOARD MEETING 11 May 2017

Specialised Services Service Specification: Inherited Bleeding Disorders

Overview of Vital Records and Public Health Informatics in CDPH

Do you suffer from diabetes? Do you want to shape the future of diabetes care?

Acute kidney injury Keeping kidneys healthy: The AKI programme board. Dr Richard Fluck, National Clinical Director (Renal) NHS England

Health Care Data Sets & Information Support Services at the UMHS

Risk Adjustment In Neurocritical care (RAIN)

FULL TEAM AHEAD: UNDERSTANDING THE UK NON-SURGICAL CANCER TREATMENTS WORKFORCE

SMASH! 1 Introduction

An Overall Vision for AMCs in Healthcare Reform. The Brookings Institution April 27, Victor J Dzau, MD

Research and Development Strategy

The New Clinical Research Landscape Incentives, Opportunities and Support Offered by the NIHR

Research in Primary Care

Using Evidence to Support the Business Case the route to adoption

National Diabetes Audit Implementation Guidance

Excess mortality among people with serious mental illness: a quality issue. Veena Raleigh Senior Fellow, The King s Fund

AMGEN S APPROACH TO VALUE- BASED HEALTHCARE IN EUROPE

Esteban de Manuel (Kronikgune) CareWell Project coordinator 30 September 2016, Bad Hofgastein, Austria

London (South) Comprehensive Local Research Network (CLRN): Local Induction

Sue Brown Clinical Audit and Effectiveness Manager. Safety and Quality Committee

PEER REVIEW VISIT REPORT (MULTI-DISCIPLINARY TEAM)

Kaiser Permanente Northern California Large Scale Hypertension Control Program

Transcription:

CPRD Clinical Practice Research Datalink john.parkinson@cprd.com NCIN June 2012 Simon Davies CEO of Teenage Cancer Trust spoke to us recently about changing the current clinical trial system to auto-enrol recently diagnosed patients,. 1

John Parkinson of CPRD spoke to us recently about changing the current clinical trial system to auto-enrol randomise recently patients diagnosed in everyday patients, clinical. care And to maximally link patients EHR with clinical trial databases And to ensure that all clinical trials are fully E Welcome to the world of CPRD 2

Clinical Practice Research Datalink 3

CPRD more dimensions to data Quality NHS Clinical Linkage Real World Randomised PROs 52M+ Metrics and validation, Gold and Silver, metadata Gatekeeper approach, universal, free at point of care Unique, universally adopted NHS number Well coded data Point of Care and P3/4 trials NHS and specifically collected Large population, age, sex, s-e class, ethnicity Many national datasets Clinical Care Clinical Guidelines Observational Data New treatments Observational Research Interventional Research 4

Unlocking the potential of NHS Patient Data in Research Observational & Interventional Other Data Any data, included in an approved protocol Tesco Club Card data? environmental data 5

All England 52 million + 12 million Scotland, Wales and NI. by agreement Incremental approach UK wide data Rare diseases and outcomes Risk Management Tracking new products 4 nation studies (NICE and SMC)? Does aspirin A big have data a major study role to play Families Families who who have have only only ever ever taken taken aspirin in Many the prevention confounding of factors cancer Not ibuprofen or or paracetamol BIAS? Poor data quality 6

Unique ID 15/06/2012 Health and Wealth Agenda All research studies benefit the NHS in some way CPRD welcomes research from Pharma, Biotech, Devices & CROs Disease Knowledge Outcomes Adaptive P3/4 NIHR Site recruitment Feasibility Optimisation Lost to follow u Clinical Trials P NHS LINK Pan studies Ethics egcp Clinical Process EHR data Coding atient recruitment OBSERVATIONAL ROs First in, last out Risk - Benefit 7

Partnerships NIHR NHS Research Networks Topic specific Primary Care Comprehensive. Thousands of Researchers Thousands of Sites Diabetes, Mental Health, Children, Cancer, Stroke, Neurod. Detailed and specific expertise CPRD NCIN Specialists Centers Knowledge synergy 8

CPRD 3 key services Real world data and linked data NHS Social Care Other health related Interventional Clinical Trials PROs Bio-samples Primary Care data Planned approach with PCRN to gain up to 25% pop. coverage by end 2012 (up from 8%, now) Planned approach to extend this to maximum possible coverage of GP practices in England 9

Secondary care All Hospital (HES) data + all drugs in hospital (not ward trolley) + cancer registry data + new cancer administered drugs + other audit or disease registers + environmental data (air pollution) +? Second. Care Primary Care 25% Air pollution Data OA SLAM Central Birth Hosp Rx 25% Labs Hospital HES Data English 52M Roster File Implants Registry Biologics Cancer Registry Other Other Registry Registry Audit 40 NHS NIHR Topic Specific Diabetes Kids Stroke Mental Health Cancer Neuro-D Central Mortality Renal Registry CVD 9 Social Care Census Data 10

CPRD Data access Gp OnLine Data Data Cuts based upon cohort GOLD + For added Power GP Data Cut SILVER + detailed Hospital Data HES + Disease Regs. + Audit data + other CPRD TRACK-marts Pregnancy Children Drug Track Device Track Cohort Track Cost Track Vac Track Niche Track PRO Track 11

CPRD Interventional efficiency * Clinical Trials Working in partnership with NIHR Point of Care randomisation ecrf P3/P4 * Samples * PRO collections enabled CPRD Point of Care randomisation In one GP EHR - InPS On-going inclusion in EMIS/TPP Auto-detection of patients via EHR On screen messages Randomisation Normal prescription All data in EHR 12

CPRD Interventional efficiency Efficacy.effectiveness.real world P3.adaptive Feasibility Optimisation NIHR Sites e Linked Real World Data Powerful Tool Real World Data Powerful Tool ecrfs EHR Central Recruitment S + P CTMS Low Loss To follow up Link to other data Dash Boards Just in time egcp EHR Follow up CPRD Want to know more REGISTER Register at CPRD.com Medication and devices Drug utilisation-compliance and persistence Pharmacovigilance Pharmacoepidemiology Pharmacoeconomics Life cycle planning Licence extension research Comparative effectiveness research Clinical outcomes Patient Reported Outcomes Public health research Epidemiology Health Services research Risk management research Risk-benefit research Risk score development Cutting edge research Clinical trials Genetic, geno-pheno studies CPRD observational data resources and services Disease and drug registers Pan European and US data Particular Disease areas CNS, Gastro, CVD, Diabetes, Skin, Oncology, etc 13

Thank you john.parkinson@cprd.com 14